To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.


Feature Video
Dr Noopur Raje opens this program with a brief discussion on the basics of multiple myeloma. She describes what the disease is, highlights key risk factors, and explains how she helps educate her patients on their diagnosis. Cynthia Harrington discusses her role as a nurse practitioner when working with multiple myeloma patients and why a team-based approach between healthcare providers and the patient is important.
Kristie L. Kahl
Outcomes associated with subcutaneous injections of Darzalex (daratumumab) appeared similar to IV administration in patients with relapsed or refractory myeloma, according to the phase 3 COLUMBA trial.
Heather Stringer
Patients with multiple myeloma find relief from side effects, thanks to newer drug combinations.
Arlene Weintraub
Researchers are using innovative technology to hunt down hidden cancer cells.
Brielle Benyon
The Food and Drug Administration (FDA) approved a split-dosing regimen for Darzalex (daratumumab) for the treatment of patients with multiple myeloma.
Alexandra Guadagno
Obesity may be to blame for increasing rates of certain cancers in young adults.
Caroline Seymour
Splitting up Darzalex dosing had comparable results to standard dosing schedules in patients with myeloma.
Brielle Benyon
From World Cancer Day to top performers and athletes, here is a quick overview of what is making headlines in the cancer space.
Brielle Benyon
Multiple myeloma is a type of blood cancer that originates in the bones. Here’s what you need to know about the disease.
Bill Wimbiscus
All in all, I’m very pleased with being able to get my oral chemo directly from my clinic’s pharmacy. The staff knows me and they know my doctor.
Toronto’s Jeff Lipton, PhD, MD, FRCPC, shares his thoughts on the outlook for blood cancers.

Sign In

Not a member? Sign up now!
Continue without login

Sign Up

Patient Caregiver Advocate Other